Skip to main content
رجوع
AZN logo

AstraZeneca PLC

جودة البيانات: 100%
AZN
NYSE Healthcare Drug Manufacturers - General
KWD 187.14
▲ KWD 1.36 (0.73%)
القيمة السوقية: 145.06B
نطاق اليوم
KWD 186.44 KWD 188.72
نطاق 52 أسبوعًا
KWD 122.48 KWD 212.71
حجم التداول
1,363,292
متوسط 50 يوم / 200 يوم
KWD 193.92 / KWD 169.71
الإغلاق السابق
KWD 185.78

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (631 نظير)

المقياس السهم وسيط القطاع
P/E 14.2 0.3
P/B 3.0 3.0
ROE % 22.9 3.7
Net Margin % 17.5 3.8
Rev Growth 5Y % 11.9 10.0
D/E 0.6 0.2

السعر المستهدف للمحللين

Hold
KWD 105.50 -43.6%
Low: KWD 103.00 High: KWD 108.00
مكرر الربحية المستقبلي
18.18
ربحية السهم المستقبلية
KWD 10.30
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
63.04B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 16.10
KWD 15.11 – KWD 16.73
81.14B 5
FY2029 KWD 14.41
KWD 13.52 – KWD 14.97
76.46B 2
FY2028 KWD 12.93
KWD 9.59 – KWD 14.37
71.45B 7

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-10 KWD 2.09 KWD 2.12 +1.4%
2025-11-06 KWD 2.29 KWD 2.38 +3.9%
2025-07-29 KWD 2.16 KWD 2.18 +0.9%
2025-04-29 KWD 2.25 KWD 2.48 +10.2%
2025-02-06 KWD 2.07 KWD 2.10 +1.4%
2024-11-12 KWD 2.04 KWD 2.08 +2.0%
2024-07-25 KWD 1.97 KWD 1.98 +0.5%
2024-04-25 KWD 1.91 KWD 2.06 +7.9%

Dividend History

7 yr streak

Yield

0.04%

Payout Ratio

0.50%

Growth (3Y)

3.29%

Growth (5Y)

2.40%

Ex-Date Payment Date Amount Yield
Feb 20, 2026 Mar 23, 2026 KWD 2.15 1.56%
Aug 08, 2025 Sep 08, 2025 KWD 0.52 2.23%
Feb 21, 2025 Mar 24, 2025 KWD 1.05 2.19%
Aug 09, 2024 Sep 09, 2024 KWD 0.50 1.79%
Feb 22, 2024 Mar 25, 2024 KWD 0.99 2.30%
Aug 10, 2023 Sep 11, 2023 KWD 0.47 2.10%
Feb 23, 2023 Mar 27, 2023 KWD 0.97 2.15%
Aug 11, 2022 Sep 12, 2022 KWD 0.46 2.26%
Feb 24, 2022 Mar 28, 2022 KWD 0.97 2.47%
Aug 12, 2021 Sep 13, 2021 KWD 0.44 2.46%
Feb 25, 2021 Mar 29, 2021 KWD 0.95 2.96%
Aug 13, 2020 Sep 14, 2020 KWD 0.44 2.51%
Feb 27, 2020 Mar 30, 2020 KWD 0.95 3.03%
Aug 08, 2019 Sep 09, 2019 KWD 0.45 3.23%
Feb 28, 2019 Mar 27, 2019 KWD 0.95 3.42%
Aug 09, 2018 Sep 10, 2018 KWD 0.45 3.61%
Feb 15, 2018 Mar 19, 2018 KWD 0.95 4.23%
Aug 09, 2017 Sep 11, 2017 KWD 0.45 4.82%
Feb 15, 2017 Mar 20, 2017 KWD 0.95 4.90%
Aug 10, 2016 Sep 12, 2016 KWD 0.45 4.15%

النقاط الرئيسية

Revenue grew 11.93% annually over 5 years — strong growth
Earnings grew 45.77% over the past year
ROE of 22.93% indicates high profitability
Net margin of 17.46% shows strong profitability
Generating 11.77B in free cash flow
P/E of 14.15 — trading at a low valuation

النمو

Revenue Growth (5Y)
11.93%
Revenue (1Y)8.63%
Earnings (1Y)45.77%
FCF Growth (3Y)33.85%

الجودة

Return on Equity
22.93%
ROIC13.15%
Net Margin17.46%
Op. Margin23.40%

الأمان

Debt / Equity
0.61
Current Ratio0.94
Interest Coverage8.11

التقييم

P/E Ratio
14.15
Forward P/E18.18
P/B Ratio2.98
EV/EBITDA12.30
Dividend Yield0.04%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 8.63% Revenue Growth (3Y) 13.23%
Earnings Growth (1Y) 45.77% Earnings Growth (3Y) 31.23%
Revenue Growth (5Y) 11.93% Earnings Growth (5Y) 209.34%
Profitability
Revenue (TTM) 58.74B Net Income (TTM) 10.26B
ROE 22.93% ROA 8.99%
Gross Margin 81.90% Operating Margin 23.40%
Net Margin 17.46% Free Cash Flow (TTM) 11.77B
ROIC 13.15% FCF Growth (3Y) 33.85%
Safety
Debt / Equity 0.61 Current Ratio 0.94
Interest Coverage 8.11
Dividends
Dividend Yield 0.04% Payout Ratio 0.50%
Dividend Growth (3Y) 3.29% Dividend Growth (5Y) 2.40%
Consecutive Div Years 7 yrs
Valuation
P/E Ratio 14.15 Forward P/E 18.18
P/B Ratio 2.98 P/S Ratio 2.47
PEG Ratio 0.07 Forward PEG N/A
EV/EBITDA 12.30 Fwd EV/EBITDA 5.18
Forward P/S 2.30 Fwd Earnings Yield 5.50%
FCF Yield 8.11%
Market Cap 145.06B Enterprise Value 169.05B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 58.74B 54.07B 45.81B 44.35B 37.42B
Net Income 10.26B 7.04B 5.96B 3.29B 112.00M
EPS (Diluted) 13.08 4.50 7.62 4.22 0.16
Gross Profit 48.11B 43.87B 37.54B 31.96B 24.98B
Operating Income 13.74B 10.00B 8.19B 3.76B 1.06B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 114.07B 104.04B 101.12B 96.48B 105.36B
Total Liabilities 65.36B 63.16B 61.95B 59.43B 66.08B
Shareholders' Equity 48.67B 40.79B 39.14B 37.04B 39.27B
Total Debt 29.70B 30.11B 28.62B 29.14B 30.69B
Cash & Equivalents 5.71B 5.49B 5.84B 6.17B 6.33B
Current Assets 28.72B 25.83B 25.05B 22.59B 26.24B
Current Liabilities 30.62B 27.87B 30.54B 26.29B 22.59B

درجات الاستراتيجيات

This stock passed the criteria for 5 strategies

Score = fit strength (0–100)
Rank = position among all matches
#305 of 1052
55
#137 of 218
35
#264 of 332
38
Custom Balanced Risk
#60 of 151
48
Custom Lower Risk
#71 of 140
45

النشاط الأخير

دخل Cash Flow Compounder
Mar 24, 2026
دخل Capital Light Compounder
Mar 24, 2026
دخل Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026
دخل Balanced Risk
Mar 24, 2026
دخل Lower Risk
Mar 24, 2026